|
Office Locations:
|
9920 Pacific Heights Blvd., Suite 150
San Diego, CA 92121
Phone: 212-935-7780
Fax: 212-935-6878
| | |
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses. HealthpointCapital manages $800 million in institutional capital, having closed in 2007 HealthpointCapital Partners II, LP, at $420 million. As of June 2007, HealthpointCapital had completed 12 investments, creating five platform companies in the orthopedic and dental industries since 2004. All investments had been made pursuant to the firm's focus on making proprietary investments which capitalize on the most compelling trends in the musculoskeletal industry, in which the firm is able to purchase a controlling or significant equity stake in growth businesses. To date, over $325 million in equity capital has been invested. The firm has completed the successful initial public offering of Alphatec Spine and the full sale of Nexa Orthopedics. On a combined basis, all portfolio companies have increased revenues more than 2.5 times from the initial time of investment, with an average holding period of just 1.5 years. The firm maintains a proprietary database of more than 1,500 companies.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|